Dr. Pawan Kumar Singh

Dr. Pawan Kumar Singh is one of India's leading Haemato-Oncologists and Bone Marrow Transplant (BMT) specialists with more than 15 years of experience in treating complex blood disorders and hematological cancers. He is widely recognized for his expertise in performing advanced hematopoietic stem cell transplants, including matched sibling, matched unrelated donor (MUD), haploidentical, and autologous bone marrow transplants for both adult and pediatric patients.

Having completed his DM in Clinical Haematology from AIIMS, New Delhi, Dr. Singh has successfully performed over 1,000 bone marrow transplants and has extensive experience in managing leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia, sickle cell disease, and other complex blood disorders. He is also known for handling high-risk transplant cases and incorporating modern treatment approaches such as targeted therapies, immunotherapy, CAR-T cell therapy, and graft manipulation.

Apart from his clinical practice, Dr. Singh actively contributes to medical research and academic publications, making him one of the most respected names in the field of Hemato-Oncology and Bone Marrow Transplantation.

Berufserfahrung

• Previously associated with Yatharth Group of Hospitals as Group Director, Hemato-Oncology & BMT
• Director, Department of Hematology and Bone Marrow Transplantation, Shalby Sanar International Hospital, Gurugram
• Director, Centre for Bone Marrow Transplantation, BLK-Max Super Speciality Hospital, New Delhi
• Senior Consultant and Head of Department, Hemato-Oncology and Bone Marrow Transplantation, Artemis Hospital, Gurugram
• Associate Consultant, Hemato-Oncology and Bone Marrow Transplantation, Jaypee Hospital, Noida
• Senior Resident, Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi
• Senior Registrar, Department of Hematology, Christian Medical College (CMC), Vellore

• MBBS
• MD
• DM (Klinische Hämatologie)

• Leukämie
• Lymphom:
• Multiples Myelom
• Myelodysplastische Syndrome (MDS)
• Aplastische Anämie
• Thalassämie
• Sichelzellenanämie
• Blutungs- und Gerinnungsstörungen
• Congenital Neutropenia & SCID

• Behandlung der aplastischen Anämie
• Knochenmark-Transplantation
• CAR-T-Zell-Therapie
• Leukämiebehandlung
• Multiple Myelombehandlung
• Behandlung von Sichelzellenanämie
• Thalassämie-Behandlung
• High-dose and induction chemotherapy (AML, ALL, MPAL)
• Hochrisiko- und komplexe Transplantationsfälle
• Graft manipulation and T-cell–depleted haploidentical BMT

• Indische Gesellschaft für Hämatologie und Bluttransfusion
• Europäische Vereinigung für Hämatologie

• Nachwuchspreis
• Young Scholar Bursary Award:
• Clinical Excellence Recognitions